growth/size/body
• body weight is significantly reduced from around 5 weeks of age
|
• mice exhibit reduced weight gain from around 5 weeks of age
|
skeleton
• bone surface area/bone volume ratio in femurs is increased (nearly doubled) at 8 weeks but not 20 weeks of age
|
• adipose-derived mesenchymal stem cells treated with osteogenic induction medium show reduced osteoblast differentiation
|
• bone mineral content is reduced at 8 and 20 weeks of age
|
• bone mineral density is reduced at 8 and 20 weeks of age, however mineralization does improve with aging
|
• trabecular bone volume/total volume ratio in femurs is reduced by about half at 8 and 20 weeks of age
• however, no differences in cortical bone values are seen
|
• a small reduction in trabecular number in femurs at 20 weeks of age, but not at 8 weeks
|
• trabecular spacing of femurs is increased at 8 and 20 weeks of age
|
• trabecular thickness of femurs is reduced at 8 weeks of age and to a lesser degree at 20 weeks of age
|
osteoporosis
(
J:358220
)
• lower serum PINP levels indicating reduction in bone osteogenesis
|
• lower serum PINP and higher CTX-I levels indicating weakened collagen secretion and unusually active degradation; PINP production reduces but CTX-I level remains stable with age, indicating a sustained bone absorption
• both the percentage and number of TRAP+ osteoclasts on the trabecular surface is increased indicating continuously active osteoclasts
|
• femurs exhibit decreased stiffness at 8 and 20 weeks of age
• while stiffness increases by 20 weeks of age, stiffness is still smaller than in wild-type at this age
|
• lower mechanical strength
|
• femurs bare a smaller maximum load
• while maximum load increases by 20 weeks of age, they are still smaller than in wild-type at this age
|
• femurs exhibit reduced post-yield displacement and plasticity
|
• femurs exhibit lower post-yield displacement, post-yield energy, and work-to-fracture indicating more brittle bones
• however, no spontaneous fractures are seen
|
cellular
• adipose-derived mesenchymal stem cells treated with osteogenic induction medium show reduced osteoblast differentiation
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
osteogenesis imperfecta type 1 | DOID:0110334 |
OMIM:166200 |
J:358220 |